Le Lézard
Classified in: Health
Subjects: TDS, FVT

BD to Present at the Barclays Global Healthcare Conference

FRANKLIN LAKES, N.J., March 8, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Barclays Global Healthcare Conference on Wednesday, March 14, 2018, at 1:35 p.m. ET.

A live webcast of BD's presentations can be accessed from the BD corporate website at www.bd.com/investors and will be available for replay through Wednesday, March 21, 2018. 

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help improve patient outcomes, improve the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to better diagnose disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com.

Kristen Cardillo, Communications ? 201-847-5657
Monique N. Dolecki, Investor Relations ? 201-847-5378

SOURCE BD (Becton, Dickinson and Company)

These press releases may also interest you

at 02:00
Brammer Bio ("Brammer"), a best-in-class viral vector contract development and manufacturing organization (CDMO) for companies developing gene-modified cell therapies and in vivo gene therapies, announces recent leadership appointments to support the...

at 01:00
WASHINGTON, March 20, 2018 /PRNewswire-PRWeb/ -- The American Academy of Nursing released its policy brief urging nurses to have an increased role in enhancing health literacy for patient populations. Health literacy is a precursor to health, and...

at 00:01
For the second consecutive year, total payments to care for individuals living with Alzheimer's or other dementias are projected to surpass a quarter of a trillion dollars ($277 billion), which includes an increase of nearly $20 billion over last...

at 00:01
Case Western Reserve University School of Medicine has been named the #1 medical school in Ohio, according to the annual ranking of graduate schools released today by U.S. News & World Report. The school was also ranked 25th of all research-oriented...

19 mar 2018
Helix BioPharma Corp. ("Helix" or the "Company"), a clinical stage immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announces its financial results for its fiscal quarter ended January 31,...

19 mar 2018
Tevosol, Inc. ("Tevosol" or the "Company") today announces: (i) changes to its senior management team; (ii) additions to the Company's Advisory Board; and (iii) the beginning of the Company's first human Investigator Lead Trial ("ILT").  These...

News published on 8 march 2018 at 16:30 and distributed by: